Edwards Lifesciences Corp (EW) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: $751.20M2017: $1.09B2018: $748.20M2019: $1.15B2020: $897.60M2021: $1.69B2022: $1.50B2023: $1.31B2024: $1.38B2025: $1.26B$1.26B
2016Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$1.26B-8.3%
2024$1.38B+5.3%
2023$1.31B-12.6%
2022$1.50B-11.4%
2021$1.69B+88.3%
2020$897.60M-21.7%
2019$1.15B+53.3%
2018$748.20M-31.3%
2017$1.09B+45.0%
2016$751.20M